Clinical Trial Update: Tofacitnib for the Treatment of Alopecia Areata and Variants [Phase 2]

View source ↗

Summary

This document reports a completed Phase 2 clinical trial of tofacitinib for alopecia areata and its variants (alopecia totalis and alopecia universalis) with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata
• Alopecia Totalis
• Alopecia Universalis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Yale University | Conditions: Alopecia Areata (AA), Alopecia Totalis (AT) | Phase 2 | Status: COMPLETED | Results posted: 2017-04-04